Tag: GSK
GSK and Empirico ink US$745 million deal on experimental COPD drug
Global biopharma company GSK has entered a worldwide exclusive license agreement with US-based clinical-stage biotechnology company Empirico for EMP-012, an experimental small interfering RNA (siRNA) therapy being tested for chronic obstructive pulmonary disease (COPD). The deal includes an US$85 million […]















